Le Lézard
Classified in: Health, Business
Subjects: NPT, SVY, WOM

Stand Up for APA Launches Non-Invasive Prenatal Testing (NIPT) Coverage Scorecard for Fortune 100 Companies, Urges CEOs to Ensure their Employee Health Plans Cover NIPT


SAN DIEGO, Nov. 24, 2020 /PRNewswire/ -- Stand Up for APA, a nonprofit working to ensure that all women in the United States receive access to the most accurate non-invasive prenatal testing options, today announced the launch of a new online Non-Invasive Prenatal Testing (NIPT) Coverage Scorecard, and that letters have been sent to the CEOs of Fortune 100 companies that use UnitedHealthcare and Aetna for their employee health insurance, informing them that their providers do not provide unrestricted NIPT coverage for all pregnant women. UnitedHealthcare and Aetna are the remaining two major health insurance companies that still fail to provide unrestricted NIPT coverage for all women, as recommended by the professional medical society guidelines from the American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM).

Stand Up for APA Launches NIPT Coverage Scorecard, Urges Fortune 100 CEOs to Ensure Employee Health Plans Cover NIPT

"While many large companies provide excellent maternal benefits for its employees, they must also recognize the importance of ensuring access is available to the best prenatal care, including unrestricted coverage of NIPT," said Brianna Wetherbe, Director and Board Member of Stand Up for APA.

Stand Up for APA's newly launched online scorecard rates Fortune 100 companies into one of three categories:

"UnitedHealthcare and Aetna remain outliers and refuse to follow the recommended guidelines outlined by the American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM) that endorse unrestricted NIPT coverage for all pregnant women," said Wetherbe. "To be a company that truly supports their female employees, it must provide all their female employees with the best available prenatal and maternal healthcare options, which is why we are urging the CEOS of companies that use Aetna or UnitedHealthcare for their health insurance to reach out to the insurers and insist them to fully and permanently cover NIPT for all pregnant women. The health and wellbeing of female employees at these companies depend on it."

To learn more about NIPT access and Stand Up for APA, please visit: standup4apa.org.

Stand Up for Accurate Prenatal Answers (Stand Up for APA) is a nonprofit founded by mothers for mothers, working to ensure that all women in the United States are treated equally by receiving the most accurate, non-invasive prenatal genetic screening information available about the health of their baby, regardless of race, color, age, or socioeconomic status. We are driven to remove limitations related to insurance coverage and income or age discrimination that prevent many pregnant women from being offered the most accurate prenatal screening information available.

SOURCE Stand Up for APA


These press releases may also interest you

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...

at 14:04
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...

at 14:04
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...

at 14:00
Help at Home, the leading national provider of innovative, high-quality, home care services, today announced that it is encouraged by the Administration's continued recognition of the value of the home care industry and its critical role in support...

at 13:46
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of...



News published on and distributed by: